University of Campania 'Luigi Vanvitelli'
Italy
History
The Schizophrenia Network builds on the European Group for Research in Schizophrenia (EGRIS), founded in 1996. EGRIS became part of ECNP in 2010, before continuing independently in 2014. To broaden scope and foster collaboration, ECNP established the current Network, dedicated to bridging clinical and preclinical research and addressing critical unmet needs in schizophrenia.
As Chairs of the ECNP Schizophrenia Network, we are proud of our achievements in uniting researchers across Europe and validating innovative assessment tools. Looking forward, our ambition is to expand translational research, strengthen mentorship for young scientists, and promote gender balance and diversity. Together, we aim to generate impactful knowledge that improves treatments and outcomes for people with schizophrenia.
Goals
1
Advance translational research in schizophrenia.
2
Foster collaboration between preclinical and clinical scientists across Europe.
3
Develop and validate novel assessment tools and interventions.
4
Disseminate findings to improve care and patient outcomes.
Core members
| Member name | Institution | City | Country |
| Celso Arango | Hospital General Universitario Gregorio Marañon | Madrid | Spain |
| Emre Bora | Dokuz Eylül University | Izmir | Turkey |
| István Bitter | Semmelweis University | Budapest | Hungary |
| Michael Davidson | Minerva Neurosciences | Tel Aviv | Israel |
| Sonia Dollfus | CHU de Caen Normandie | Caen | France |
| Bjørn Ebdrup | Mental Health Centre Glostrup University of Copenhagen | Copenhagen | Denmark |
| Emilio Fernandéz-Egea | University of Cambridge | Cambridge | United Kingdom |
| W. Wolfgang Fleischhacker | Medical University Innsbruck | Innsbruck | Austria |
| Paolo Fusar-Poli | King's College London | London | United Kingdom |
| Silvana Galderisi | University of Campania 'Luigi Vanvitell' | Naples | Italy |
| Andreas Heinz | Charité – Universitätsmedizin Berlin | Berlin | Germany |
| Alex Hofer | Medical University Innsbruck | Innsbruck | Austria |
| René S. Kahn | University Medical Center Utrecht | Utrecht | The Netherlands |
| Stefan Kaiser | University of Geneva | Geneva | Switzerland |
| Tilo Kircher | University of Marburg | Marburg | Germany |
| Jan Libiger | Charles University Faculty of Medicine | Hradec Králové | Czech Republic |
| Ingrid Melle | Institute of Clinical Medicine - University of Oslo | Oslo | Norway |
| Armida Mucci | University of Campania "Luigi Vanvitelli" | Naples | Italy |
| Mette Ødegaard Nielsen | University of Copenhagen | Copenhagen | Denmark |
| Janusz K. Rybakowski | Poznan University of Medical Sciences | Poznan | Poland |
| Gabriele Maria Sachs | Medical University of Vienna | Vienna | Austria |
| Myrto Samara | University of Thessaly | Larissa | Greece |
| Florian Schlagenhauf | Charité – Universitätsmedizin Berlin | Berlin | Germany |
| Nikos Stefanis | National and Kapodistrian University of Athens | Athens | Greece |
| Marc Weiser | Sheba Medical Center | Tel Hashomer | Israel |
| Ruud van Winkel | KU Leuven | Leuven | Belgium |
| Inge Winter-van Rossum | University Medical Center Utrecht | Utrecht | The Netherlands |
Shell members
| Member name | Institution | City | Country |
| Dieter Naber | University Medical Center Hamburg-Eppendorf | Hamburg | Germany |
| Joseph Peuskens | UPC KU Leuven | Kortenberg | Belgium |
Early Career Academy members
| Member name | Institution | City | Country |
| Shokouh Arjmand | Karolinska Institute | Stockholm | Sweden |
| Stefan Jerotic | Clinical Centre of Serbia | Belgrade | Serbia |
| Vicent Llorca-Bofí | Neuroscience Institute- Hospital Clínic Barcelona | Barcelona | Spain |
| Mishal Qubad | Goethe University Frankfurt- University Hospital | Frankfurt am Main | Germany |
Publications
-
2008Kahn et al.
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
The Lancet -
2009Davidson et al.
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open label clinical trial (EUFEST).
American Journal of Psychiatry -
2013Galderisi et al.
Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial.
European Neuropsychopharmacology